Review ArticleIs the serotonin transporter involved in the pathogenesis of pulmonary hypertension?☆
Section snippets
Serotonin
Serotonin is an endogenous vasoactive indolamine substance found mainly in enterochromaffin tissue, brain, and blood platelets. The neutral amino acid l-tryptophan is the primary precursor of serotonin, the synthesis of which first involves hydroxylation of the benzene ring of tryptophan by the rate-limiting monooxygenase tryptophan hydroxylase to form 5-hydroxytryptophan and, second, decarboxylation of its aminocarboxy terminal group by an aromatic l-amino-acid decarboxylase to form 5-HT.
The
The serotonin transporter
5-HTT belongs to a large family of integral membrane proteins that are responsible for terminating the action of neurotransmitters released from neurons. This family also includes α-aminobutyric acid transporters and the norepinephrine and dopamine transporters.16 In addition to 5-HT reuptake into neurons, 5-HTT is responsible for uptake of indolamine by platelets and endothelial and vascular SMCs. The 5-HT uptake process is driven mainly by the electrochemical potential associated with Na+ and
5-HTT and PASMC proliferation
Serotonin in the micromolar range is a known mitogen for SMCs isolated from bovine, porcine, and rat aorta, as well as rat and bovine pulmonary arteries.11, 12, 21 The mechanisms by which 5-HT causes SMC proliferation may vary among cell types and species. Most cellular transduction systems for 5-HT seem to depend on initiation of the signal by a cell-surface receptor. Several subtypes of 5-HT receptors have been characterized pharmacologically and cloned. These receptors may interact with
Transduction of 5-HT signals beyond the serotonin transporter
Mitogenesis of PASMCs induced by 5-HT appears to occur by way of signaling through a MAP kinase-dependent pathway.29 Exposure of bovine PASMCs to 5-HT increases phosphorylation of ERK1 and ERK2 MAP kinase five- to sevenfold within 5 minutes. Omission of Na+ from the incubating medium or cell pretreatment with 5-HT-uptake inhibitors prevents the stimulation of MAP kinase by 5-HT. Moreover, inhibition of MAP kinase kinase by 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD-98059) inhibits
Effect of hypoxia on 5-HTT expression and PASMC proliferation
Hypoxia is a recognized stimulus that affects both the tone and structure of pulmonary blood vessels. Acute hypoxia causes vasoconstriction of distal pulmonary arteries, with a subsequent increase in pulmonary arterial pressure. Moreover, chronic hypoxia is associated with hypertrophy and hyperplasia of PASMCs. This process results in increased thickness of the walls of muscular arteries and extension of muscularization to precapillary arteries, which are normally nonmuscularized. One possible
5-HTT and pulmonary vascular remodeling
A role for 5-HT in the development of hypoxic PH is further suggested by our data showing that continuous intravenous infusion of indolamine during a two-week exposure to severe hypoxia aggravated PH in rats.41 Indeed, along with higher pulmonary arterial pressure and more severe right ventricular hypertrophy, we noted that the percentage of muscularized arteries at the alveolar duct and alveolar wall level was greater in rats exposed for long periods to 10% O2 and continuously infused with
5-HTT as the target for drugs that increase the risk of PH
The effects of 5-HT on the pulmonary vessels became a matter of renewed interest when consumption of anorectic drugs interfering with 5-HT uptake and metabolism was noticed in a number of patients with PPH. An association between the anorectic drug aminorex and PPH was first reported in the 1960s, which led to its withdrawal from the market. In the 1980s, PPH was associated with the use of fenfluramine or its derivatives, and it was subsequently estimated that the disease occurs approximately
References (52)
- et al.
Primary pulmonary hypertension in a patient with a familial platelet storage disease: role of serotonin
Am J Med
(1990) - et al.
Chronic treatment with the phentermine combined with fenfluramine lowers plasma serotonin
Am J Cardiol
(2000) - et al.
A review of central 5-HT receptors and their function
Neuropharmacology
(1999) - et al.
Superoxide as an intermediate signal for serotonin-induced mitogenesis
Free Radic Biol Med
(1998) - et al.
Superoxide scavenging effect of Ginkgo biloba extract on serotonin-induced mitogenesis
Biochem Pharmacol
(1998) Hypoxia-inducible gene expression
Respir Physiol
(1995)- et al.
Hypoxia response elements in the aldose A, enolase 1, and lactate dehydrogenase A gene contain essential binding sites for hypoxia-inducible factor 1
J Biol Chem
(1996) - et al.
The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat
Eur J Pharmacol
(1993) - et al.
Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAS in rat dorsal raphe
Mol Brain Res
(1996) Primary pulmonary hypertension
N Engl J Med
(1997)
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
N Engl J Med
Häufen sich die primär vasculären formen des chronischen cor pulmonale?
Schweiz Med Wochenschr
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension
Circulation
Factors influencing the idiopathic development of pulmonary hypertension in the fawn-hooded rat
Am Rev Respir Dis
High plasma serotonin levels in primary pulmonary hypertension: effects of long-term Epoprostenol (prostacyclin) therapy
Arterioscler Thromb Vasc Biol
Dexfenfluramine as a cellular mitogen signals through the formation of superoxide anion
FASEB J
Primary pulmonary hypertension: a pathologic study of the lung vessels in 156 clinically diagnosed cases
Circulation
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin
Circ Res
Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture
Circ Res
Histamine, bradykinin, 5-hydroxytryptamine and their antagonists
Ultrastructure localization of 5-hydroxytryptamine in blood platelet
Nature
Turnover of 5-hydroxytryptamine (serotonin) in tissue
Proc Soc Exp Biol Med
Neurotransmitter transporters in the central nervous system
Pharmacol Rev
Substrates and temperature differentiate ion flux from serotonin flux in a serotonin transporter
Neuropharmacology
Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter
J Neurochem
Regulation of antidepressant-sensitive serotonin transporters
Cited by (0)
- ☆
Reprint requests: S. Eddahibi, INSERM U492 et Département de Physiologie, CHU Henri Mondor, 94010 Créteil, France; e-mail: [email protected].